ALS Research Gets Boost with $16 Million Grant

The California Institute of Regenerative Medicine (CIRM) has given a $16 million grant to Brainstorm Cell Therapeutics, Inc., a stem cell developer in Israel. The grant will support a phase III trial for amyotrophic lateral sclerosis (ALS). ALS: An Overview ALS is a progressive disorder of painless muscle weakness. It is also known as Lou [Read More]

MS Patients Flock to Russia for Stem Cell Therapy

People from all around the world are flocking to Moscow, Russia, for innovative stem cell therapies for MS. Multiple sclerosis is a crippling disease that affects the brain and spinal cord. MS is an autoimmune disease that is unpredictable and affects different people in different ways. Clinical management and pharmacotherapy can help relieve symptoms and [Read More]

Treating Parkinson’s Disease

Scientists Reprogram Brain Cells to Treat Parkinson’s Scientists in Europe have developed a new method of reprogramming brain cells to treat Parkinson’s disease. The experiments were conducted in mice to see if some of the movement disorders that characterize Parkinson’s could be corrected. Parkinson’s Disease: An Overview Parkinson’s disease is the result of neurons (brain [Read More]

Stem Cells for Joints and Crohn’s Disease

John is a 48-year-old Caucasian male with a history of joint disease secondary to trauma suffered as a collegiate athlete. He loves playing catch with his sons, but his Acromioclavicular (AC joint) arthritis, as well as a right shoulder cartilage tear, made this father and son playtime a painful event to endure. An X-ray revealed [Read More]

There’s Hope for Severe Myasthenia Gravis

Hope for Severe Myasthenia Gravis

Myasthenia gravis, a neuromuscular condition in which patients must endure fluctuating degrees of debilitating fatigue and weakness, is a chronic autoimmune disease affecting about 20 people in every 100,000 in the United States. A retrospective observational study led by Dr. Harold Atkins at the University of Ottawa in Ontario, Canada, published in JAMA Neurology, has [Read More]

Get our newsletter for the latest news & updates.

Share the knowledge: